IFU, Alta Semper Capital, AAIC Investment, Creadev & Ohara Pharmaceutical investment into MYDAWA’s operations in Kenya

Lead party: Impact Fund Denmark (investor/buyer)Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed). Target: ION Kenya Ltd (MYDAWA) (private company) · Sector: Consumer Discretionary, Healthcare, Medical Supplies, Drug Retailers · Countries of operation: Kenya Transaction type: Investment · Asset class: Private Equity · Strategy: Growth Equity · Instrument: Equity ·…


Lead party: Impact Fund Denmark (investor/buyer)

Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).

Target: ION Kenya Ltd (MYDAWA) (private company) · Sector: Consumer Discretionary, Healthcare, Medical Supplies, Drug Retailers · Countries of operation: Kenya

Transaction type: Investment · Asset class: Private Equity · Strategy: Growth Equity · Instrument: Equity · Fund: Alta Semper Growth Fund II

Investors/buyers: Impact Fund Denmark, Alta Semper Capital LLC, Creadev SAS, Ohara Pharmaceutical Co., Ltd., AAIC Investment Pte. Ltd.

Legal advisers: not identified in the source record.

Source: announced 1 May 2025. Original announcement: dabafinance.com.